E’Ola Ephedrine Hydrochloride Sales Barred Under FDA Settlement
This article was originally published in The Tan Sheet
FDA may order Biogenics, d/b/a E'Ola International, to "discontinue all manufacturing, processing, packing, labeling and distribution" if it believes the supplement marketer is selling a misbranded or adulterated product, according to a recent consent decree
You may also be interested in...
FDA is planning to create a dispute resolution system for manufacturing inspections
Approximately 140,000 bottles of E'Ola International's AMP II Pro Drops, worth roughly $2.8 mil., were seized by U.S. Marshals Oct. 31
Perrigo promotes in pricing, planning